Literature DB >> 3871492

Induction of pancreatic carcinomas in rats with N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine: histopathology.

D S Longnecker, B D Roebuck, E T Kuhlmann, T J Curphey.   

Abstract

The carcinogenicity of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine (HPOP) for rat pancreas was evaluated. Two-week-old male LEW rats were given a single ip injection of HPOP, 160 mg/kg body weight; the rats were autopsied 4, 6, or 12 months later. Histologic examination showed that the pancreata contained multiple foci of atypical acinar cells and nodules of atypical acinar cells (AACN), acinar cell adenomas, localized carcinomas, and carcinomas. The incidence of carcinomas was 77%. The carcinomas were composed of poorly differentiated acinar cells and ductlike structures. Pancreatic ducts were unaffected. The prominence of AACN, the histologic type of the neoplasms, and the absence of hyperplastic changes in ductal epithelium suggest that the pancreatic carcinomas were derived from acinar cells. The incidence of liver cell carcinomas and pulmonary adenomas was similar to that of localized pancreatic carcinomas. Neoplasms of other organs were less frequent. HPOP has been shown to induce pancreatic carcinomas in hamsters but has not previously been reported to be a pancreatic carcinogen in rats.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871492

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Multicentric focal acinar cell hyperplasia and hepatocyte-like cell metaplasia are induced by nitrosomethylurea in rat pancreas.

Authors:  B Monis; M A Valentich; R Urrutia; M Rivolta
Journal:  Int J Pancreatol       Date:  1991-02

2.  Experimental evidence for the origin of ductal-type adenocarcinoma from the islets of Langerhans.

Authors:  P M Pour; L Weide; G Liu; K Kazakoff; M Scheetz; I Toshkov; Y Ikematsu; M A Fienhold; W Sanger
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.

Authors:  V T Smit; A J Boot; A M Smits; G J Fleuren; C J Cornelisse; J L Bos
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

4.  Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.

Authors:  J I Paz-Bouza; T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

Review 5.  Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis.

Authors:  Wanglong Qiu; Gloria H Su
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

Review 6.  Animal models of exocrine pancreatic carcinogenesis.

Authors:  M S Rao
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Modifying effects of soybean trypsin inhibitor on development of eosinophilic nodules and basophilic foci in the exocrine pancreas of male Sprague-Dawley rats treated with 4-hydroxyaminoquinoline 1-oxide.

Authors:  F Furukawa; K Imaida; T Imazawa; Y Hayashi; M Takahashi
Journal:  Jpn J Cancer Res       Date:  1992-01

8.  Carcinogenic potency of N-nitrosomethyl(2-hydroxypropyl)amine and other metabolic relatives of N-nitrosobis(2-hydroxypropyl)amine by single intraperitoneal injection on the lung of rats.

Authors:  Y Yokose; K Yamamoto; A Nakajima; H Eimoto; H Maruyama; Y Mori; Y Konishi
Journal:  Jpn J Cancer Res       Date:  1988-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.